Consistently with the preclinical finding, a positive correlation was observed between steatosis grade and circulating PCSK9 in subjects with a risk of non-alcoholic steatohepatitis (NASH)57. Here, PCSK9 is linked to metabolic dysfunction-associated steatohepatitis.